Endometriosis

Showing NaN - NaN of 13

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Endometriosis Trial in Worldwide (75 mg linzagolix tablet, 200 mg linzagolix tablet, Placebo tablet to match 75 mg linzagolix

Active, not recruiting
  • Endometriosis
  • 75 mg linzagolix tablet
  • +5 more
  • Dothan, Alabama
  • +46 more
Jan 12, 2023

Endometriosis Trial in United States (OG-6219, Placebo)

Recruiting
  • Endometriosis
  • College Park, Georgia
  • +12 more
Dec 9, 2022

Endometriosis Trial in Worldwide (Placebo, OBE2109)

Completed
  • Endometriosis
  • Chandler, Arizona
  • +85 more
Jun 27, 2022

Endometriosis Trial in Worldwide (BAY1817080, Elagolix, Placebo)

Completed
  • Endometriosis
  • Birmingham, Alabama
  • +141 more
Jun 17, 2022

Endometriosis Trial in Worldwide (Relugolix, Estradiol/norethindrone acetate)

Active, not recruiting
  • Endometriosis
  • Andalusia, Alabama
  • +168 more
May 31, 2022

Endometriosis Trial in Canada, Puerto Rico, United States (Estradiol/Norethindrone Acetate, Placebo for Elagolix, Elagolix)

Active, not recruiting
  • Endometriosis
  • Estradiol/Norethindrone Acetate
  • +3 more
  • Birmingham, Alabama
  • +196 more
Feb 14, 2022

Women Receiving Standard of Care for Treatment of Pelvic Pain

Terminated
  • Endometriosis
  • +2 more
    • Birmingham, Alabama
    • +116 more
    Nov 16, 2021

    Endometriosis Trial in United States (Tanezumab, Placebo)

    Terminated
    • Endometriosis
    • Tanezumab
    • Placebo
    • Mobile, Alabama
    • +29 more
    Apr 5, 2021

    Bone Mineral Density in Uterine Fibroids or Endometriosis

    Completed
    • Uterine Fibroid
    • Endometriosis
      • Mobile, Alabama
      • +62 more
      Nov 6, 2020

      Intestinal Permeability and Endometriosis

      Completed
      • Endometriosis
      • lactulose:mannitol (L:M) oral challenge
      • Chattanooga, Tennessee
      • +1 more
      Apr 27, 2020

      Endometriosis Trial in Worldwide (Placebo, Levonorgestrel, Anastrozole)

      Completed
      • Endometriosis
      • Placebo
      • +3 more
      • San Diego, California
      • +143 more
      Dec 6, 2017

      Dysmenorrhea, Dyspareunia, Endometriosis Trial in Worldwide (ERB-041)

      Completed
      • Dysmenorrhea
      • +3 more
      • Montgomery, Alabama
      • +69 more
      Dec 7, 2007